Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Most patients do not experience significant weight loss in the first week, as your body needs time to adjust, and the dosage is increased gradually to help minimize side effects
(2004) 2003:Cd004497
As a GLP-1 receptor agonist , semaglutide works through completely different pathways
While there is no official link between tirzepatide and restless legs syndrome in current medical literature or FDA safety data, patients experiencing new or worsening leg symptoms while taking tirzepatide should discuss these concerns with their healthcare provider
Important safety note Like GLP-1 receptor agonists, CagriSema is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
US$ 21.54
US$ 25.57
US$ 21.08
US$ 21.35
US$ 25.31
US$ 25.18
US$ 28.44
